12 European countries and EMBL have established the Euro-BioImaging interim board on 31 March 2014. The interim board is the decision-making body during the interim phase. Currently, the interim board consists of 16 members (15 countries + EMBL). Its key tasks are to decide on the legal model and governance structure, finance plan and user access policy based on the models recommended by the preparatory phase partners.
Delegates of the Czech Republic in the Euro-BioImaging Interim Board:
June 10 - 11, Biology Centre, Ceske Budejovice
Pavel Hozák se stal čerstvým absolventem MBA programu pro manažery výzkumných infrastruktur na Milánské univerzitě Bicocca jako první z České Republiky.